FDA Adverse Event Malfunction Summary report: N

SERVO-N

MDR report key: 8422037 · Received March 14, 2019

Report

Report Number
8010042-2019-00167
Event Type
Malfunction
Date Received
March 14, 2019
Date of Event
February 24, 2019
Report Date
May 22, 2019
Manufacturer
MAQUET CRITICAL CARE AB
Product Code
CBK
PMA / PMN Number
K151814
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
SC
Reporter Occupation
BIOMEDICAL ENGINEER

Narratives

Additional Manufacturer Narrative · 0

GETINGE USA SALES, LLC (IMPORTER) IS SUBMITTING THIS REPORT ON BEHALF OF MAQUET CRITICAL CARE AB (MANUFACTURER). REF. EXEMPTION #: E2018003. GETINGE USA SALES, LLC, 45 BARBOUR POND DRIVE, WAYNE, NJ 07470. CONTACT PERON: (B)(4).

Additional Manufacturer Narrative · 0

GETINGE USA SALES, LLC (IMPORTER) IS SUBMITTING THIS REPORT ON BEHALF OF MAQUET CRITICAL CARE AB (MANUFACTURER). REF. EXEMPTION #: E2018003. GETINGE USA SALES, LLC, 45 BARBOUR POND DRIVE, WAYNE, NJ 07470. CONTACT PERON: (B)(4). THE VENTILATOR WAS INVESTIGATED ON SITE AND THE NOZZLE UNITS FROM THE O2 AND THE AIR GAS MODULE WAS REPLACED. THE NOZZLE UNITS HAVE NOT BEEN RECEIVED. EVALUATION OF THE RECEIVED DEVICE LOGS SHOWS THAT THE MATCHING EVENT ON FEBRUARY 24 DURING THE TIME PERIOD 06:55 TO 07:20 THE DAY AFTER. IF THIS CONDITION OCCURS DURING VENTILATION, THE PATIENT MAY RECEIVE AN AMOUNT OF OXYGEN IN THE GAS MIXTURE THAT DEVIATE FROM THE EXPECTED AND ALARMS WILL BE ACTIVATED TO THE CONDITION. THE ROOT CAUSE HAS NOT BEEN FULLY ESTABLISHED, BUT OUR CONCLUSION IS THAT IT WAS LIKELY DUE TO THE NOZZLE UNIT, A MAINTENANCE PART OF THE AIR GAS MODULE.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE VENTILATOR ALARMED FOR LOW O2 CONCENTRATION DURING PATIENT TREATMENT. THERE WAS NO PATIENT HARM. (B)(4).

Description of Event or Problem · 0

IMPORTER REF. #: (B)(4). MANUFACTURER REF. #: (B)(4).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
216425 SERVO-N VENTILATOR, CONTINUOUS, FACILITY USE CBK MAQUET CRITICAL CARE AB

Patients

Seq Age Sex Outcome Treatment
1